Parker-Hannifin (PH) Delivers Record Results and Raises Long-Term Targets, Shares Rise +6.7%
Key Takeaways
- Parker-Hannifin delivered record fiscal 2026 fourth-quarter sales of $5.755 billion, rising 9.8% year-over-year and surpassing Wall Street's consensus estimate of approximately $5.57 billion.
- Adjusted earnings per share (EPS) reached a record $9.27, easily topping analyst expectations of $8.27 and representing 21% growth compared to the prior-year quarter.
- Full-year fiscal 2026 sales exceeded $20 billion for the first time in the company's history, landing at $21.5 billion with organic growth of 6.6%.
- Adjusted segment operating margin expanded to 28.0% in Q4, up 110 basis points (bps) from a year earlier, while the full-year margin hit a record 27.3%.
- Management raised its long-term margin target to 30% by fiscal 2031 and issued fiscal 2027 adjusted EPS guidance of $34.75 at the midpoint.
- Shares surged approximately 6.7% following the release, reflecting strong investor approval of the beat-and-raise quarter.
Why This Earnings Report Stands Out
Parker-Hannifin's fiscal 2026 fourth-quarter report, released on August 6, 2026, capped what management described as the strongest year in the company's century-long history. As a Fortune 250 global leader in motion and control technologies, PH sits at the intersection of industrial manufacturing and aerospace — two sectors that have experienced uneven demand over the past several years. This earnings report matters because it provides a comprehensive read on the health of global industrial activity, supply chain normalization, and the powerful tailwinds in commercial and defense aerospace. Coming on the heels of three strategic acquisitions — Curtis Instruments, Filtration Group Corporation, and CIRCOR's aerospace business — the results also offered the first clear picture of how Parker's portfolio reshaping is translating into financial performance. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The Quarter's Numbers in Detail
Parker-Hannifin reported fiscal 2026 fourth-quarter (ended June 30, 2026) sales of $5.755 billion, a 9.8% increase from $5.243 billion in the same period a year ago. Organic sales — which strip out currency effects, acquisitions, and divestitures — grew 8.0%, marking the strongest quarter of the fiscal year. Net income on a generally accepted accounting principles (GAAP) basis was $1.091 billion, or $8.54 per diluted share, up 19% from $7.15 per share in the prior-year quarter. On an adjusted basis, which excludes one-time items, net income reached $1.186 billion and EPS came in at $9.27, a 21% jump from $7.69 a year earlier.
Both top- and bottom-line results comfortably exceeded consensus estimates. Analysts had projected adjusted EPS of approximately $8.27 on revenue of around $5.57 billion. The $1.00 EPS beat represented a roughly 12% positive surprise, driven by strong execution across all three operating segments.
Segment-level performance showed broad-based strength. Aerospace Systems led the way with record quarterly sales of $1.9 billion and organic growth of 13.4%, marking the fourth consecutive year of double-digit organic expansion in that segment. North American operations generated $2.2 billion in sales with 5% organic growth, while International sales hit a record $1.6 billion with 6.5% organic growth. Total company backlog climbed 16% year-over-year to a new record of $12.8 billion, with the aerospace backlog alone reaching $8.5 billion.
For the full fiscal year, Parker-Hannifin posted record sales of $21.5 billion (up 8.3% reported, 6.6% organic), record adjusted EPS of $32.31 (up 18%), and record operating cash flow of $4.4 billion, which represented 20.3% of sales. Free cash flow reached $3.9 billion, up 17%, with a conversion rate of 107% relative to adjusted net income. From what I see, the consistency across segments reinforces the durability of these trends.
Investor Response to the Results
Investors responded decisively to Parker-Hannifin's results. Shares climbed approximately 6.7% to around $1,063 on August 6, approaching the stock's 52-week high of $1,098.80. The positive reaction was fueled not only by the magnitude of the earnings beat but also by management's decision to raise its long-term adjusted segment operating margin target to 30% by fiscal 2031 — a full 300 bps above the prior target of 27% — and the issuance of fiscal 2027 guidance that calls for continued momentum. With adjusted EPS of $34.75 at the midpoint of the fiscal 2027 range, the outlook implies roughly 8% growth off an already elevated base, suggesting management sees durable demand trends across both industrial and aerospace end markets. The record $12.8 billion backlog further reinforced the bullish narrative, providing visible revenue coverage well into the next fiscal year. I’m watching this closely as the backlog offers tangible visibility.
Looking Ahead: Guidance and What to Monitor
Parker-Hannifin enters fiscal 2027 on notably strong footing. Management guided to reported sales growth of 5.5% to 8.5% (approximately 7% at the midpoint), with an adjusted segment operating margin of about 27.7% and adjusted EPS in the range of $34.25 to $35.25. The guidance reflects confidence in sustained aerospace momentum, a gradual recovery in shorter-cycle industrial markets, and continued benefits from the company's Win Strategy operational framework.
Several factors warrant close attention in the quarters ahead. First, the integration of three major acquisitions — Curtis Instruments, Filtration Group Corporation, and CIRCOR's Commercial and Defense Aerospace Business — will test management's execution capabilities. These deals collectively represent over $15 billion in capital deployment and are designed to shift the portfolio toward higher-margin, longer-cycle businesses. Smooth integration could accelerate margin expansion, while any missteps could temporarily weigh on results.
Second, the aerospace cycle remains the single most important swing factor. With a record $8.5 billion aerospace backlog and 13.4% organic growth in the segment, Parker-Hannifin is heavily levered to continued strength in commercial aerospace aftermarket demand and defense spending. Any disruption to air travel demand, aircraft production rates, or government defense budgets would have an outsized impact on the company's growth trajectory.
Third, investors should monitor order trends across the North American and International industrial segments. While both regions posted solid Q4 results — 5% and 6.5% organic growth, respectively — the pace of broader industrial recovery remains uneven across geographies and end markets. Management noted that total orders were up 19% on a three-month rolling comparison, an encouraging signal, but sustained order momentum is essential to converting the record backlog into revenue and to supporting the fiscal 2027 growth outlook.
Finally, Parker-Hannifin's capital allocation strategy will remain in focus. The company returned nearly $2 billion to shareholders in fiscal 2026 through dividends (including an 11% increase marking 70 consecutive fiscal years of dividend growth) and share repurchases, while reducing net debt to 1.4 times adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization). How management balances further debt reduction, M&A (mergers and acquisitions) opportunities, and shareholder returns will shape the investment case heading into the new fiscal year.
Enhancing Research with AI Tools
In my regular review of earnings reports and market opportunities, I often turn to Tickeron’s AI Screener to filter ideas across technical patterns, fundamentals, and industry benchmarks. It helps surface comparable setups efficiently when evaluating names like PH alongside peers, keeping the process focused and data-driven.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.
PH in downward trend: price dove below 50-day moving average on August 31, 2026
PH moved below its 50-day moving average on August 31, 2026 date and that indicates a change from an upward trend to a downward trend. In 24 of 38 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 63%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PH as a result. In 48 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 53%.
The Moving Average Convergence Divergence Histogram (MACD) for PH turned negative on August 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In 25 of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at 48%.
The 10-day moving average for PH crossed bearishly below the 50-day moving average on September 04, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
The Aroon Indicator for PH entered a downward trend on September 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where PH's RSI Oscillator exited the oversold zone, 19 of 21 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 8 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +2.49% 3-day Advance, the price is estimated to grow further. Considering data from situations where PH advanced for three days, in 244 of 337 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
PH may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Profit vs. Risk Rating rating for this company is 7 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 38 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. PH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.776) is normal, around the industry mean (5.521). P/E Ratio (33.365) is within average values for comparable stocks, (64.605). PH's Projected Growth (PEG Ratio) (3.182) is slightly higher than the industry average of (1.876). Dividend Yield (0.008) settles around the average of (0.019) among similar stocks. P/S Ratio (5.663) is also within normal values, averaging (191.817).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of motion and control technologies and systems
Industry IndustrialMachinery
Advertisement